术前CT扫描有助于预测慢加急性3级肝衰竭肝移植后的结局
回顾性纳入82例2010年1月至2020年1月间接受肝移植的3级慢加急性肝衰竭患者,采用移植前3个月内增强腹部CT筛选预后因素。多因素分析显示脾大、肝萎缩和下腔静脉直径比值为独立CT预后因素,基于此构建的简易评分以10分为界区分高危与低危组,1年生存率分别为27%与67%(p<0.001)。
要点
- 脾大(5分)、肝萎缩(5分)和下腔静脉直径比<0.2(12分)构成CT预后评分。
- 评分>10分高危组1年生存率27%,≤10分低危组67%(p<0.001)。
- 该CT评分与TAM评分联合应用时为独立预测因素。
核心结论
- 移植前增强腹部CT对3级慢加急性肝衰竭患者选择有显著影响,可用于预测肝移植后1年生存。
研究设计与样本
- 回顾性纳入2010年1月至2020年1月接受肝移植的3级慢加急性肝衰竭患者82例,均有移植前3个月内增强腹部CT,主要终点为1年死亡率。
关键影像表现/征象
- 脾大(p=0.021;HR=5.6(1.29-24.1))为独立CT预后因素。
- 肝萎缩(p=0.05;HR=2.93(1.01-10.64))为独立CT预后因素。
- 下腔静脉直径比值(p<0.0001;HR=12.7(3.4-92))为独立CT预后因素。
诊断标准与关键数值
- 预后评分:脾大5分、肝萎缩5分、下腔静脉直径比<0.2为12分; cutoff 10分区分高危(>10分)与低危(≤10分)。
- 高危组1年生存率27% vs 低危组67%(p<0.001)。
临床应用与阅片要点
- 术前增强腹部CT可评估脾大、肝萎缩和下腔静脉直径比值,辅助预测肝移植后1年生存。
- CT评分可与TAM评分联合用于3级慢加急性肝衰竭患者的风险分层。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: The aim of this study was to identify the prognostic value of pre-operative imaging to predict post-transplantation survival in critically ill cirrhotic patients with severe acute-on-chronic liver failure (ACLF).
METHODS: Patients with grade 3 ACLF who underwent liver transplantation between January 2010 and January 2020 and with available contrast-enhanced abdominal computed tomography (CT) performed less than 3 months before LT were retrospectively included (n = 82). Primary endpoint was 1-year mortality. Imaging parameters (sarcopenia, liver morphology and volumetry, and signs of portal hypertension) were screened and tested to build a prognostic score.
RESULTS: In the multivariate analysis, three independent CT-derived prognostic factors were found: splenomegaly (p = 0.021; HR = 5.6 (1.29-24.1)), liver atrophy (p = 0.05; HR = 2.93 (1.01-10.64)), and vena cava diameter ratio (p < 0.0001; HR = 12.7 (3.4-92)). A simple prognostic score was proposed, based on the presence of splenomegaly (5 points), liver atrophy (5 points), and vena cava diameter ratio < 0.2 (12 points). A cutoff at 10 points distinguished a high-risk group (score > 10) from a low-risk group (score ≤ 10) with 1-year survival of 27% vs. 67% respectively (p < 0.001). It was found to be an independent predictive factor in association with the Transplantation for ACLF3 Model (TAM) score.
CONCLUSION: Pre-transplantation contrast-enhanced abdominal CT has a significant impact on selection of patients in ACLF3 in order to predict 1-year survival after LT.
KEY POINTS: • Splenomegaly, liver atrophy, and vena cava diameter ratio are independent CT-derived prognostic factors after transplantation for severe acute-on-chronic liver failure. • A simple CT-based prognostic score is an independent predictive factor, complementary to clinical and biological parameters. • The use of the CT-derived score allows stratification based on 1-year mortality for patients with otherwise uncertain prognosis with clinical and biological parameters alone.
引用
- Wackenthaler A, Molière S, Artzner T, et al. Pre-operative CT scan helps predict outcome after liver transplantation for acute-on-chronic grade 3 liver failure. Eur Radiol. 2021. PMID: 34173847. doi:10.1007/s00330-021-08131-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。